Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Strength training boosts Parkinson's Patients' daily life

NCT ID NCT07629063

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study looks at whether adding resistance (strength) exercises to standard aerobic and balance training can improve quality of life, daily activities, thinking skills, and muscle health in people with early-stage Parkinson's disease. About 34 adults aged 40-70 with mild to moderate Parkinson's will do exercises three times a week for eight weeks. Researchers will measure grip strength, walking speed, and other functions before, right after, and one month after the program ends.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Sep 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 40 to 70 years * Patients diagnosed with Modified Hoehn-Yahr stage 1-3 Parkinson's disease * Patients diagnosed with Parkinson's disease for more than 1 year * Patients who can mobilize without an assistive device Exclusion Criteria: * Patients diagnosed with Parkinson Plus syndrome * History of uncontrolled hypertension * History of uncontrolled diabetes mellitus * History of serebrovascular disease within the past 6 months * History of miyocardial infarction within the past 6 months * History of knee or hip artroplasty surgery * History of severe cardiac arrythmia * Presence of cardiac pacemaker * Presence of severe dementia * History of severe psychiatric disorders * Patients who have on dialysis * Presence of acute infection * Pregnancy * History of malignancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Early stage Parkinson's disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity Parkinson disease Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sisli Hamidiye Etfal Training and Research Hospital

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.